Search Login Register

Enoxaparin (Lovenox) Summary

Description: Low-molecular-weight fragment of heparin, having a 4-enopyranosuronate sodium structure at the non-reducing end of the chain. It is prepared by depolymerization of the benzylic ester of porcine mucosal heparin. Therapeutically, it is used as an antithrombotic agent. (From Merck Index, 11th ed)

Also Known As: Lovenox; Clexane; EMT-966; EMT-967; Enoxaparine Show All >>

Networked: 1907 relevant articles (278 outcomes, 618 trials/studies) for this Drug

Key Diseases for which Enoxaparin is Relevant

  1. Hemorrhage : 73 outcomes 128 studies in 602 results
  2. Venous Thrombosis (Deep-Vein Thrombosis) : 45 outcomes 74 studies in 295 results
  3. Venous Thromboembolism : 41 outcomes 122 studies in 333 results
  4. Myocardial Infarction : 34 outcomes 112 studies in 224 results
  5. Thrombosis (Thrombus) : 32 outcomes 38 studies in 212 results
Show All >>

Drugs Related to Enoxaparin

  1. Heparin (Liquaemin)
  2. Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
  3. rivaroxaban
  4. fondaparinux (Arixtra)
  5. Dalteparin (Dalteparin Sodium)
  6. Aspirin (Acetylsalicylic Acid)
  7. Warfarin (Coumadin)
  8. Enoxaparin (Lovenox)
  9. apixaban
  10. Factor Xa (Coagulation Factor Xa)
Show All >>

Therapies Related to Enoxaparin

  1. Arthroplasty
  2. Hip Replacement Arthroplasty (Total Hip Replacement)
  3. Knee Replacement Arthroplasty (Total Knee Replacement)
  4. Angioplasty (Angioplasty, Transluminal)
  5. Stents
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.